Skip to main content

ADVERTISEMENT

inflammatory bowel disease

Q&As
12/27/2018
Lisa Yerke, DDS, MS, from University at Buffalo, answers our questions about her research presented during a poster session at the 2018 AIBD Meeting on the use of proton pump inhibitors for IBD and its impact on periodontal disease.
Lisa Yerke, DDS, MS, from University at Buffalo, answers our questions about her research presented during a poster session at the 2018 AIBD Meeting on the use of proton pump inhibitors for IBD and its impact on periodontal disease.
Lisa Yerke, DDS, MS, from...
12/27/2018
Advances in Inflammatory Bowel Disease Network
Podcasts
12/20/2018
Dr Stephen Hanauer from Northwestern Medicine discusses the roles of TNF inhibitors and immunomodulators in managing IBD, how gastroenterologists can position the use of each therapeutic, and more.
Dr Stephen Hanauer from Northwestern Medicine discusses the roles of TNF inhibitors and immunomodulators in managing IBD, how gastroenterologists can position the use of each therapeutic, and more.
Dr Stephen Hanauer from...
12/20/2018
Advances in Inflammatory Bowel Disease Network
News
12/15/2018
In a Keynote session at the 2018 AIBD Meeting, Dr Marla Dubinsky discussed the impact of IBD on fertility and the need for a multidisciplinary approach to properly educate patients on their options.
In a Keynote session at the 2018 AIBD Meeting, Dr Marla Dubinsky discussed the impact of IBD on fertility and the need for a multidisciplinary approach to properly educate patients on their options.
In a Keynote session at the 2018...
12/15/2018
Advances in Inflammatory Bowel Disease Network
News
12/15/2018
Researchers analyzed the impact medication therapy management has on patients using injectable biologic treatments for IBD as well as on clinicians and their office staff.
Researchers analyzed the impact medication therapy management has on patients using injectable biologic treatments for IBD as well as on clinicians and their office staff.
Researchers analyzed the impact...
12/15/2018
Advances in Inflammatory Bowel Disease Network
News
12/14/2018
In a Keynote session at the 2018 AIBD Meeting, Dr James Lindsay highlighted the use of biologics and biosimilars, as well as its challenges, for the treatment of ulcerative colitis and Crohn disease.
In a Keynote session at the 2018 AIBD Meeting, Dr James Lindsay highlighted the use of biologics and biosimilars, as well as its challenges, for the treatment of ulcerative colitis and Crohn disease.
In a Keynote session at the 2018...
12/14/2018
Advances in Inflammatory Bowel Disease Network
News
12/13/2018
At the 2018 AIBD Meeting, Dr William Sandborn discusses the biologics and positioning of anti-interleukin-12 and anti-interleukin-23 agents for inflammatory bowel disease.
At the 2018 AIBD Meeting, Dr William Sandborn discusses the biologics and positioning of anti-interleukin-12 and anti-interleukin-23 agents for inflammatory bowel disease.
At the 2018 AIBD Meeting, Dr...
12/13/2018
Advances in Inflammatory Bowel Disease Network
News
12/13/2018
In a Keynote session at the 2018 AIBD Meeting, Dr Eugene Chang discusses the importance of understanding the gut microbiome, genetic pathways in microbes, and its impact on IBD.
In a Keynote session at the 2018 AIBD Meeting, Dr Eugene Chang discusses the importance of understanding the gut microbiome, genetic pathways in microbes, and its impact on IBD.
In a Keynote session at the 2018...
12/13/2018
Advances in Inflammatory Bowel Disease Network
News
12/11/2018
Dr Shilajit Kundu and colleagues evaluated data on more than 10,000 men to determine how prostate cancer affects men with and without inflammatory bowel disease.
Dr Shilajit Kundu and colleagues evaluated data on more than 10,000 men to determine how prostate cancer affects men with and without inflammatory bowel disease.
Dr Shilajit Kundu and colleagues...
12/11/2018
Advances in Inflammatory Bowel Disease Network
Podcasts
12/10/2018
Dr Jean-Frederic Colombel from Mount Sinai Medical Center discusses clinical challenges in inflammatory bowel disease for 2019, the need for a multidisciplinary approach, and more.
Dr Jean-Frederic Colombel from Mount Sinai Medical Center discusses clinical challenges in inflammatory bowel disease for 2019, the need for a multidisciplinary approach, and more.
Dr Jean-Frederic Colombel from...
12/10/2018
Advances in Inflammatory Bowel Disease Network
Podcasts
11/29/2018
Dr Mark Deneau from University of Utah Health discusses the current management of pediatric inflammatory bowel disease and primary sclerosing cholangitis, the importance of identifying patients for treatment, and more.
Dr Mark Deneau from University of Utah Health discusses the current management of pediatric inflammatory bowel disease and primary sclerosing cholangitis, the importance of identifying patients for treatment, and more.
Dr Mark Deneau from University...
11/29/2018
Advances in Inflammatory Bowel Disease Network